Key Highlights

  • Arrive AI (NASDAQ:ARAI) changed hands at USD 1.94 on November 12, 2026, a 31.50% decline on a split-adjusted basis, with roughly 327,580 shares traded, about 1.8 times a typical day's volume.
  • The 1-for-48 consolidation became effective at 12:01 a.m. on November 12, reducing shares outstanding from roughly 68.77 million to about 1.43 million.
  • The consolidation is meant to satisfy the Nasdaq USD 1.00 minimum bid requirement, with a compliance deadline of November 30, 2026 following the transfer to the Nasdaq Capital Market.
  • Second-quarter Revenue came to USD 15,000 with a net loss of USD 14.1 million and cash of USD 3.0 million, and third-quarter figures arrive on November 13.

Selling Around the Consolidation

Arrive AI (NASDAQ:ARAI) builds autonomous delivery infrastructure, such as smart mailboxes that take in parcels from drones and ground robots, mainly for healthcare and Business clients. On November 10 the firm disclosed that the 1-for-48 consolidation would start at 12:01 a.m. on November 12, with split-adjusted trading opening that morning. Forty-eight old shares became one, so the total fell from around 68.77 million to roughly 1.43 million, while authorized shares and Par Value stayed the same. Before the change the stock had finished near USD 0.053. A consolidation leaves a company's underlying worth untouched, yet first-day sell-offs are common, since holders anticipating later dilution head for the exit and certain Brokers and funds rebalance their books. The 31.50% slide in the first adjusted session matches that pattern. Nothing else negative surfaced for the day, so tying the drop to the consolidation is a reading, not a confirmed explanation. Traders weighing the stock ahead of the November 13 release will be looking for any sign that the selling has run its course.

Nasdaq Compliance and Capital Needs

The consolidation responds to pressure from the exchange. Arrive AI shifted to the Nasdaq Capital Market on October 23 and must show a closing bid of USD 1.00 or higher over the required stretch by November 30, 2026. The shares at USD 1.94 clear that bar, but another slide would put the matter back on the table. Authorized shares were not altered, so the firm holds a much larger pool of stock it could issue relative to its now-smaller count, something that tends to weigh on shares after a consolidation. Raising money is a genuine necessity: the company will most likely need fresh capital before its delivery network generates meaningful sales. Second-quarter revenue was USD 15,000, the net loss USD 14.1 million, and cash on hand USD 3.0 million at June 30; trailing net losses add up to about USD 27.6 million.

Ongoing Commercial Steps and Upcoming Results

The company keeps announcing commercial activity. On November 9 it revealed an expansion involving Hancock Health, and two days later it disclosed a strategic Investment tied to robotics company Ottonomy. Revenue for all of 2025 reached USD 113,000 and the net loss USD 12.8 million, underscoring that the business is still early. Third-quarter numbers come out before the open on November 13, with a webcast at 8:30 a.m. Eastern. Market Participants will focus on revenue gains from healthcare installations, the quarter's cash consumption, the cash position at September 30, and any remarks on financing. The screen shows trailing diluted losses of USD 0.70 per share and a Market Value of around USD 4.06 million following the decline. Clear funding direction alongside the release would ease the doubt that generally trails a major consolidation. Each item on that list will be read against the headline numbers once the results are published.

Where Things Stand

Arrive AI (NASDAQ:ARAI) lost 31.50% to USD 1.94 on November 12, 2026, its first session after a 1-for-48 consolidation intended to address Nasdaq bid price rules. Given modest revenue, steep losses and USD 3.0 million in cash at mid-year, funding is the investor focus, with third-quarter results on November 13 as the next checkpoint.